Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters-Reference-Cited by-同舟云学术

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

Published:2021-03 Issue:3 Volume:2 Page:100218
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Piepenbrink Michael S.^ORCID,Park Jun-Gyu,Oladunni Fatai S.,Deshpande Ashlesha,Basu Madhubanti,Sarkar Sanghita,Loos Andreas,Woo Jennifer,Lovalenti Phillip,Sloan Derek,Ye Chengjin,Chiem Kevin,Bates Christopher W.,Burch Reuben E.,Erdmann Nathaniel B.,Goepfert Paul A.,Truong Vu L.,Walter Mark R.,Martinez-Sobrido Luis,Kobie James J.^ORCID

Funder

Texas Biomedical Research Institute

Ariad Pharmaceuticals

University of Alabama at Birmingham

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference47 articles.

1. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China;Cai;Diabetes Care,2020

2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

3. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020;MMWR Morb. Mortal. Wkly. Rep.,2020